Frontotemporal lobar degeneration

From WikiMD's Food, Medicine & Wellness Encyclopedia

Frontotemporal Lobar Degeneration (FTLD) is a term used to describe a group of disorders characterized by progressive damage to the frontal and temporal lobes of the brain. These areas of the brain are generally associated with personality, behavior, and language.

Symptoms[edit | edit source]

The symptoms of FTLD can vary greatly from one person to another, largely depending on the areas of the brain affected. Some common symptoms include drastic changes in personality and behavior, difficulty with language, and motor problems.

Causes[edit | edit source]

The exact cause of FTLD is unknown, but it is thought to be linked to a buildup of certain proteins in the brain. Some cases of FTLD are inherited, meaning they are caused by mutations in certain genes.

Diagnosis[edit | edit source]

Diagnosing FTLD can be challenging, as its symptoms often overlap with those of other conditions, such as Alzheimer's disease and Parkinson's disease. Diagnosis typically involves a thorough medical history, physical examination, and a variety of tests to assess mental status, behavior, and language skills.

Treatment[edit | edit source]

There is currently no cure for FTLD, but there are treatments available to help manage the symptoms. These may include medications to manage behavior problems, physical therapy to help with motor problems, and speech therapy to help with language difficulties.

Prognosis[edit | edit source]

The prognosis for individuals with FTLD is generally poor, as the disease tends to progress rapidly. However, the rate of progression can vary greatly from one person to another.

See also[edit | edit source]

References[edit | edit source]


Frontotemporal lobar degeneration Resources
Doctor showing form.jpg
Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Admin, Prab R. Tumpati, MD